Skip to content Accessibility tools

Therapeutics Reporting Options Now Available in NHSN

Beginning March 30, 2026, facilities may optionally report weekly data on therapeutics administered to residents for COVID-19, influenza, and RSV using the NHSN Respiratory Pathogens and Vaccination (RPV) Module.

  • Reporting for the therapeutics data fields is optional.
  • Sign up for the April 30, 2026 webinar hosted by the NHSN Long Term Care Team and Prevention & Therapeutics Unit RPV Module.

 

More information is available in the following resources:

 

Pre-registration is required to attend the webinar on the RPV Module: April 30, 2026 | 1:00 pm ET Pre-Registration Link

  • After registering, you will receive a confirmation email with additional details about the webinar. Slides will be posted after the webinar.

 

Topics to be covered include:

  • Optional Reporting of Therapeutic Medications – Facilities can now use the RPV Module to optionally report therapeutic medications given to residents diagnosed with COVID-19, influenza, or respiratory syncytial virus (RSV).
  • Updates to the Person-Level Vaccination Form for Residents – The form now auto-calculates a resident’s vaccination status for COVID-19, influenza, and RSV.
  • Up-to-Date Definition for COVID-19 Vaccines for Quarter 1 and 2 of 2026 (12/29/25 through 6/28/26) – There is no change to the Up-to-Date definition for COVID-19 vaccines for Quarter 1 and 2 of 2026. 

 

Please submit questions to the NHSN Help Desk via NHSN-ServiceNow using the subject line “LTCF RPV Webinar.” If you are unable to access ServiceNow, please submit a question to the NHSN Help Desk via email with the same subject line.